Safemedwaste, Inc.

08/06/2024

Go Fig, Little Beeings, Sphere, Strata Platforms, RFIDKNOW, and Tabbi were accepted as South Carolina Research Authority Member Companies. Imagine Home Digital, MyUI, MyVoluntier Operations, SafeMedWaste, and Virtual Business 360 received new grant funding.

04/04/2024

NATIONAL PRESCRIPTION DRUG TAKE BACK DAY 2024!

Help protect your loved ones and the environment by properly disposing of unused prescription drugs in the home. You CAN make a difference.

Learn more: https://www.campusdrugprevention.gov/national-prescription-drug-take-back-day?utm_medium=email&utm_source=govdelivery

01/18/2024

DEA Adds Precursor Chemicals Used to Make Illicit Fentanyl to the Special Surveillance List.

This is the first update to the Special Surveillance List since it was published in 1999.

Fentanyl is the greatest threat facing Americans today. It is a threat to our public health, our public safety, and our national security, and it is the cause of the most devastating drug crisis in United States’ history. The U.S. Drug Enforcement Administration (DEA) is committed to using every t...

12/18/2023

The team at Safemedwaste, Inc. wishes everyone a safe and happy holiday season.

11/01/2023

OPERATION BOTTLENECK (October 31, 2023). DEA announces actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids.

https://www.dea.gov/press-releases/2023/10/31/dea-executes-operation-bottleneck-prevent-diversion-controlled-substances

, ,

Secure .gov websites use HTTPSA lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

10/20/2023

Don't forget to mark your calendar! The DEA drug take back day is just around the corner. Learn more about the event and drop off locations:

The drug overdose epidemic in the United States is a clear and present public health, public safety, and national security threat. DEA’s National Prescription Drug Take Back Day reflects DEA’s commitment to Americans’ safety and health, encouraging the public to remove unneeded medications fro...

10/19/2023

FDA approves new non-opioid, post-operative pain medication.

, ,

The U.S. health regulator has approved Hyloris Pharmaceuticals' drug for post-operative pain, the Belgium-based company said on Wednesday, adding that it expects to launch the non-opioid treatment in the United States by early next year.

10/09/2023

A QUICK OVERVIEW OF THE WASTE REFUND ACT: Required CMS Refunds Effective January 1, 2023.

As part of the infrastructure bill passed in 2021, the Waste Refund Act requires drug companies to reimburse Medicare for certain wasted medications leftover in single-use containers.

Healthcare facilities (hospitals, ASC's, etc.) that do not report their wastage refunds correctly could be at risk of failed audits and being charged with healthcare fraud.

Learn more about the requirements

The-infrastructure-bill-that-passed-on-Nov-15-2021-garnered-much-media-attention-for-its-focus-on-bridges-and-other-long-neglected-systems

08/11/2023

The Biden-Harris Administration Awards More Than $88 Million in Grants that Safeguard Youth Mental Health and Expand Access to Treatment for Substance Use Disorders.

If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat at 988lifeline.org. To learn how to get support for mental health, drug or alcohol issues, visit FindSupport.gov. If you are ready to locate a treatment facility or provider, you can go directly to FindTreatment.gov or call 1-800-662-HELP (4357).

, ,
https://www.samhsa.gov/newsroom/press-announcements/20230811/biden-harris-administration-awards-grants-safeguard-youth-mental-health-expand-access-treatment-substance-use-disorders?utm_source=SAMHSA&utm_campaign=f73417bd91-EMAIL_CAMPAIGN_2023_08_11_02_20&utm_medium=email&utm_term=0_-f73417bd91-%5BLIST_EMAIL_ID%5D

The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), has recently awarded more than $88 million in its continuing effort to safeguard the nation’s behavioral health. The grant programs serve a wide array of needs .....

08/02/2023

ALERT: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I

ACTION: Temporary amendment; temporary scheduling order.

SUMMARY: The Administrator of the Drug Enforcement Administration is issuing this temporary order to schedule five synthetic benzodiazepine substances: etizolam, flualprazolam, clonazolam, flubromazolam, and diclazepam, in schedule I of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of these five substances in schedule I is necessary to avoid imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.

DATES: This temporary scheduling order is effective July 26, 2023, until July 26, 2025. If this order is extended or made permanent, DEA will publish a document in the Federal Register.

05/25/2023

Okra Medical's office will be closed on Monday, May 29th in observance of the Memorial Day holiday. Regular office hours will resume on Tuesday, May 30th. On behalf of the entire Okra Medical team, we extend our heartfelt gratitude to all the fallen heroes and their families.

05/09/2023

National Fentanyl Awareness Day is taking place today Tuesday, May 9th. Illicitly manufactured fentanyl is responsible for more deaths of Americans under 50 than any other cause of death, such as heart disease, cancer, homicide, and su***de. It's important to have conversations with your children about the dangers of fentanyl and their mental well-being. Click the link below to learn more:
https://bit.ly/3HIXyJV

A day of action to raise public awareness about an urgent problem: illegally made fentanyl. Join our effort on May 9, 2022.

05/08/2023

The Substance Abuse and Mental Health Services Administration (SAMHSA) has dedicated May 7-13, 2023 as National Prevention Week. The goal of this week is to increase public awareness and prevention of mental health, and substance use disorders.

SAMHSA is an agency of the U.S. Department of Health and Human Services and is responsible for reducing the impact of substance abuse and mental illness on America's communities. They provide resources and support to healthcare providers, educators, and communities to prevent and treat mental and substance use disorders.

During National Prevention Week, SAMHSA encourages communities to organize events and activities that promote prevention and reduce the risk of mental and substance use disorders. This year's theme is ""Prevention Works, Treatment Is Effective, Recovery Is Possible,"" which emphasizes the importance of prevention, treatment, and recovery for individuals and communities.

SAMHSA has created a toolkit to help organizations plan and promote National Prevention Week. The toolkit includes ideas for events and activities, social media graphics and messages, and resources for mental and substance use disorder prevention. Click here to access the tool kit: https://bit.ly/44GUIik

By raising awareness and promoting prevention, SAMHSA hopes to reduce the number of individuals affected by mental and substance use disorders. National Prevention Week is an opportunity for communities to come together and work towards a healthier future for all.

To learn more about National Prevention Week, visit SAMHSA’s website here: https://bit.ly/3VJxNyP

05/02/2023

Welcome to “Nawlins” and the Waste360 Healthcare Conference at Ernest N. Morial Convention Center. May 2nd and 3rd.

Join us in ROOM 295 - table #7 - to learn how fast onsite chemical digestion can help your business simplify processes and reduce risks associated with controlled substance wastage management.

04/20/2023

Have questions about EPA's Management Standards for Hazardous Waste Pharmaceuticals Final Rule?
EPA has two primary reasons for introducing this final rule.

1. Address concerns raised by stakeholders regarding the difficulty in implementing the industry-oriented Resource Conservation and Recovery Act (RCRA) hazardous waste regulations for the management of hazardous waste pharmaceuticals generated at healthcare facilities and managed at reverse distributors.

2. A number of studies have documented the presence of various pharmaceutical active ingredients and metabolic by-products in surface waters and groundwater in the United States. The pharmaceuticals entering the environment, through flushing or other means, are having a negative effect on aquatic ecosystems and on fish and animal populations.

To learn more about the requirements of this new rule and how the rule addresses the above concerns, visit the link below.
http://bit.ly/41lfL8u

04/18/2023

Saturday, April 22, 2023, is DEA’s National Prescription Drug Take Back Day.

Keep them safe. Clean them out. Take them back.

This day mirrors the DEA’s commitment to Americans’ safety and health, encouraging the public to remove unneeded medications from their homes as a measure to prevent theft, misuse, and potential addiction or overdose by unintended users.

To find a collection site near you and learn more about the importance of National Prescription Drug Take Back Day, visit https://www.dea.gov/takebackday

04/13/2023

Okra Medical is excited to be attending and exhibiting at the upcoming Waste360 Healthcare Conference.

Stop by Table #7 to say hi and learn more about SafeMedWaste, our new onsite destruction product for controlled substance wastage.

If you would like to schedule a meeting during the conference, please request a day and time by contacting info@okramed.com.

Okramed.com